CASI Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $75.3M
Liabilities Breakdown FY2023
Total Liabilities: $51.1M
Asset Breakdown
Total Assets: $75.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $17.1M | 22.7% |
| Accounts Receivable | $9.6M | 12.7% |
| Inventory | $15.9M | 21.1% |
| Property, Plant & Equipment | $9.2M | 12.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $1.8M | 2.4% |
| Other Assets | $21.7M | 28.8% |
Liabilities Breakdown
Total Liabilities: $51.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.4M | 8.7% |
| Long-Term Debt | $18.9M | 37.0% |
| Other Liabilities | $27.8M | 54.3% |